88 related articles for article (PubMed ID: 22260362)
1. Effects of phosphonoformic acid and renagel on renal type IIa sodium-dependent phosphate cotransporter mRNA expression in hyperphosphatemia rats.
Zeng M; Wang X; Wang X; Zhao X
Ren Fail; 2012; 34(3):358-63. PubMed ID: 22260362
[TBL] [Abstract][Full Text] [Related]
2. Effect of hyperphosphatemia on gene expression of the Na-Pi cotransporter in rats.
Zhang C; Shi LM; Li Y; Zhu QG; Jin CL; Wang HP; Zhou L; Hu XP; Zhang L; Wang H; Yuan GJ; Xu L; Zhao YK; Chou Y
Genet Mol Res; 2016 Jan; 14(4):19404-10. PubMed ID: 26782594
[TBL] [Abstract][Full Text] [Related]
3. Magnesium stimulates renal phosphate reabsorption.
Thumfart J; Jung S; Amasheh S; Krämer S; Peters H; Sommer K; Biber J; Murer H; Meij I; Querfeld U; Wagner CA; Müller D
Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1126-33. PubMed ID: 18701629
[TBL] [Abstract][Full Text] [Related]
4. RenaGel efficacy in severe secondary hyperparathyroidism.
Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism.
Mizobuchi M; Ogata H; Hatamura I; Koiwa F; Saji F; Shiizaki K; Negi S; Kinugasa E; Ooshima A; Koshikawa S; Akizawa T
Nephrol Dial Transplant; 2006 Apr; 21(4):911-6. PubMed ID: 16384827
[TBL] [Abstract][Full Text] [Related]
6. Phosphate excretion and phosphate transporter messenger RNA in uremic rats treated with phosphonoformic acid.
Brooks DP; Ali SM; Contino LC; Stack E; Fredrickson TA; Feild J; Edwards RM
J Pharmacol Exp Ther; 1997 Jun; 281(3):1440-5. PubMed ID: 9190881
[TBL] [Abstract][Full Text] [Related]
7. Genistein affects parathyroid gland and NaPi 2a cotransporter in an animal model of the andropause.
Pantelic J; Ajdzanovic V; Medigovic I; Mojic M; Trifunovic S; Milosevic V; Filipovic B
J Physiol Pharmacol; 2013 Jun; 64(3):361-8. PubMed ID: 23959733
[TBL] [Abstract][Full Text] [Related]
8. Effect of sevelamer hydrochloride on bone in experimental uremic rats.
Kuwahara M; Inoshita S; Terada Y; Sasaki S
Ther Apher Dial; 2009 Feb; 13(1):42-8. PubMed ID: 19379169
[TBL] [Abstract][Full Text] [Related]
9. Hyperphosphatemia-induced hyperparathyroidism in 5/6 nephrectomized rats: development of a new animal model.
Jiang Y; Wang M
Chin Med J (Engl); 2008 Dec; 121(23):2440-3. PubMed ID: 19102965
[TBL] [Abstract][Full Text] [Related]
10. A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients.
Chertow GM; Dillon M; Burke SK; Steg M; Bleyer AJ; Garrett BN; Domoto DT; Wilkes BM; Wombolt DG; Slatopolsky E
Clin Nephrol; 1999 Jan; 51(1):18-26. PubMed ID: 9988142
[TBL] [Abstract][Full Text] [Related]
11. Regulation of NaPi-IIa mRNA and transporter protein in chronic renal failure: role of parathyroid hormone (PTH) and dietary phosphate (Pi).
Elhalel MD; Wald H; Rubinger D; Gal-Moscovici A; Inoue M; Levi M; Popovtzer MM
Pflugers Arch; 2004 Dec; 449(3):265-70. PubMed ID: 15452708
[TBL] [Abstract][Full Text] [Related]
12. Evidence of a parathyroid hormone-independent chronic effect of estrogen on renal phosphate handling and sodium-dependent phosphate cotransporter type IIa expression.
Guttmann-Rubinstein L; Lichtstein D; Ilani A; Gal-Moscovici A; Scherzer P; Rubinger D
Horm Metab Res; 2010 Apr; 42(4):230-6. PubMed ID: 20119884
[TBL] [Abstract][Full Text] [Related]
13. Regulation of parathyroid cell gene expression in experimental uremia.
Shvil Y; Naveh-Many T; Barach P; Silver J
J Am Soc Nephrol; 1990 Jul; 1(1):99-104. PubMed ID: 2104257
[TBL] [Abstract][Full Text] [Related]
14. Role of the sodium-dependent phosphate cotransporters and absorptive endocytosis in the uptake of low concentrations of uranium and its toxicity at higher concentrations in LLC-PK1 cells.
Muller DS; Houpert P; Cambar J; Hengé-Napoli MH
Toxicol Sci; 2008 Feb; 101(2):254-62. PubMed ID: 17998273
[TBL] [Abstract][Full Text] [Related]
15. Renal mineral handling in normal rats treated with sevelamer hydrochloride (Renagel), a noncalcemic phosphate binder.
Nagano N; Miyata S; Obana S; Eto N; Fukushima N; Burke SK; Wada M
Nephron; 2001 Nov; 89(3):321-8. PubMed ID: 11598397
[TBL] [Abstract][Full Text] [Related]
16. [The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
Zwiech R; Dryja P; Łacina D; Króliczak V; Chrul S; Kacprzyk F
Wiad Lek; 2011; 64(1):9-14. PubMed ID: 21812357
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of regucalcin enhances its nuclear localization and suppresses L-type Ca2+ channel and calcium-sensing receptor mRNA expressions in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
Nakagawa T; Yamaguchi M
J Cell Biochem; 2006 Nov; 99(4):1064-77. PubMed ID: 16767692
[TBL] [Abstract][Full Text] [Related]
18. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.
Neves KR; Graciolli FG; dos Reis LM; Pasqualucci CA; Moysés RM; Jorgetti V
Kidney Int; 2004 Dec; 66(6):2237-44. PubMed ID: 15569312
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.
Patzer L; Hernando N; Ziegler U; Beck-Schimmer B; Biber J; Murer H
Kidney Int; 2006 Nov; 70(10):1725-34. PubMed ID: 17003823
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model.
Sugiura H; Matsushita A; Futaya M; Teraoka A; Akiyama KI; Usui N; Nagano N; Nitta K; Tsuchiya K
PLoS One; 2018; 13(3):e0191706. PubMed ID: 29518087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
